[to top of second column]
The institute and the American Lung Association sponsored the study. AstraZeneca LLP, the maker of Nexium, provided the medicine used in the study.
In an editorial in the journal, Drs. Koichiro Asano and Hidekazu Suzuki of Keio University School of Medicine in Tokyo recommended that a study be done comparing surgical repair of gastroesophageal reflux with medication in asthma patients with reflux. They noted there's evidence the surgery improves asthma control. They said the failure of Nexium in this study does not mean there's no relationship between worsening asthma and gastroesophageal reflux.
On the Net:
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
< Recent articles
Back to top
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Law & Courts |
Spiritual Life |
Health & Fitness |
Calendar | Letters to the Editor